{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:54:12Z","timestamp":1791561252410,"version":"4.3.4"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Donor derived infections (DDIs) in pediatric kidney transplant recipients remain challenging to diagnose and can result in serious morbidity and mortality. This review summarizes the current guidelines and recommendations for prevention, diagnosis, and treatment of unexpected DDIs in pediatric kidney transplant recipients. We provide a contemporary overview of DDI terminology, surveillance, epidemiology, and recommended approaches for assessing these rare events with an emphasis on the pediatric recipient. To address prevention and risk mitigation, important aspects of donor and pediatric candidate evaluations are reviewed, including current Organ Procurement and Transplantation Network (OPTN) and American Society of Transplantation (AST) recommendations. Common unexpected DDI encountered by pediatric transplant teams including multi-drug resistant organisms, tuberculosis, syphilis, West Nile Virus, toxoplasmosis, Chagas disease, strongyloidiasis, candidiasis, histoplasmosis, coccidioidomycosis, and emerging infections such as COVID-19 are discussed in detail. Finally, we consider the general challenges with management of DDIs and share our experience with a novel application of next generation sequencing (NGS) of microbial cell-free DNA that will likely define a future direction in this field.<\/jats:p>","DOI":"10.3389\/fped.2023.1167069","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:36:48Z","timestamp":1682051808000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevention, diagnosis, and management of donor derived infections in pediatric kidney transplant recipients"],"prefix":"10.3389","volume":"11","author":[{"given":"Katrina","family":"Epperson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarkson","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ingulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/ajt.16178","article-title":"Ten years of donor-derived disease: a report of the disease transmission advisory committee","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Transplant"},{"key":"B2","year":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1600-6143.2011.03493.x","article-title":"An update on donor-derived disease transmission in organ transplantation","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e13547","DOI":"10.1111\/ctr.13547","article-title":"Donor-derived infections: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Wolfe","year":"2019","journal-title":"Clin Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrneph.2014.159","article-title":"Donor-derived infection--the challenge for transplant safety","volume":"10","author":"Fishman","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e13540","DOI":"10.1111\/tid.13540","article-title":"Hepatitis C-positive donor to negative recipient kidney transplantation: a real-world experience","volume":"23","author":"Jandovitz","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.34067\/KID.0004592020","article-title":"Survey of clinician opinions on kidney transplantation from hepatitis C virus positive donors: identifying and overcoming barriers","volume":"1","author":"Lentine","year":"2020","journal-title":"Kidney 360"},{"key":"B8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5980\/jpnjurol1989.89.62","article-title":"[A case report of use of horseshoe kidney as renal transplant from live donor]","volume":"89","author":"Aikawa","year":"1998","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/TP.0b013e318236cd02","article-title":"Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation","volume":"92","author":"Garzoni","year":"2011","journal-title":"Transplantation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1111\/j.1600-6143.2008.02397.x","article-title":"Donor infection and transmission to the recipient of a solid allograft","volume":"8","author":"Len","year":"2008","journal-title":"Am J Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13115","article-title":"Pediatrics and donor-derived disease transmission: the US OPTN experience","volume":"22","author":"Green","year":"2018","journal-title":"Pediatr Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"B13","year":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/TP.0000000000003523","article-title":"COVID-19 and solid organ transplantation: a review article","volume":"105","author":"Azzi","year":"2021","journal-title":"Transplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/cid\/cis519","article-title":"Transmission of infection with human allografts: essential considerations in donor screening","volume":"55","author":"Fishman","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/ajt.15488","article-title":"Risk factors for multidrug-resistant organisms among deceased organ donors","volume":"19","author":"Anesi","year":"2019","journal-title":"Am J Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1111\/j.1600-6143.2012.04100.x","article-title":"Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice","volume":"12","author":"Singh","year":"2012","journal-title":"Am J Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/003335491312800403","article-title":"PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation","volume":"128","author":"Seem","year":"2013","journal-title":"Public Health Rep"},{"key":"B19","year":""},{"key":"B20","doi-asserted-by":"publisher","first-page":"e13405","DOI":"10.1111\/petr.13405","article-title":"Use of public health service increased risk kidneys in pediatric renal transplant recipients","volume":"23","author":"Meyers","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00467-019-04276-w","article-title":"Utilizing increased risk for disease transmission (IRD) kidneys for pediatric renal transplant recipients","volume":"34","author":"Hwang","year":"","journal-title":"Pediatr Nephrol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/ajt.15231","article-title":"Kidney transplant outcomes associated with the use of increased risk donors in children","volume":"19","author":"Kizilbash","year":"2019","journal-title":"Am J Transplant"},{"key":"B23","year":""},{"key":"B24","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1097\/TXD.0000000000000852","article-title":"Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission","volume":"5","author":"White","year":"2019","journal-title":"Transplant Direct"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e12971","DOI":"10.1111\/tid.12971","article-title":"Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: a comprehensive review","volume":"20","author":"Abad","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1111\/j.1600-6143.2012.04205.x","article-title":"Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report","volume":"12","author":"Morris","year":"2012","journal-title":"Am J Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ajt.12094","article-title":"Screening of donor and recipient in solid organ transplantation","volume":"13","author":"Fischer","year":"2013","journal-title":"Am J Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1111\/ajt.17145","article-title":"Organ transplantation using COVID-19-positive deceased donors","volume":"22","author":"Bock","year":"2022","journal-title":"Am J Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e13548","DOI":"10.1111\/ctr.13548","article-title":"Screening of donor and candidate prior to solid organ transplantation-guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Malinis","year":"2019","journal-title":"Clin Transplant"},{"key":"B30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1600-6143.2009.02992.x","article-title":"Nucleic acid testing (NAT) of organ donors: is the \u201cbest\u201d test the right test? A consensus conference report","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/hep.29704","article-title":"Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients","volume":"67","author":"Bari","year":"2018","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/ajt.13283","article-title":"Transmission of hepatitis C virus from organ donors despite nucleic acid test screening","volume":"15","author":"Suryaprasad","year":"2015","journal-title":"Am J Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1010120115451","article-title":"Hemodilution due to blood loss and transfusion and reliability of cadaver tissue donor infectious disease testing","volume":"1","author":"Eastlund","year":"2000","journal-title":"Cell Tissue Bank"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e13150","DOI":"10.1111\/tid.13150","article-title":"The role of preemptive antimicrobial therapy in kidney recipients of urine-only positive donor cultures","volume":"21","author":"Cabrera","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e13783","DOI":"10.1111\/tid.13783","article-title":"Impact of donor multidrug-resistant organisms on solid organ transplant recipient outcomes","volume":"24","author":"Anesi","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"B36","year":""},{"key":"B37","doi-asserted-by":"publisher","first-page":"e14141","DOI":"10.1111\/petr.14141","article-title":"TB In paediatric kidney transplant recipients\u2014a single-centre experience","volume":"26","author":"Makanda-Charambira","year":"2022","journal-title":"Pediatr Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e13259","DOI":"10.1111\/ctr.13259","article-title":"Mycobacterium tuberculosis after solid organ transplantation: a review of more than 2000 cases","volume":"32","author":"Abad","year":"2018","journal-title":"Clin Transplant"},{"key":"B39","year":""},{"key":"B40","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1111\/j.1600-6143.2006.01461.x","article-title":"Transmission of syphilis by solid organ transplantation","volume":"6","author":"Cortes","year":"2006","journal-title":"Am J Transplant"},{"key":"B41","year":""},{"key":"B42","doi-asserted-by":"publisher","first-page":"e14896","DOI":"10.1111\/ctr.14896","article-title":"Serologic follow-up of solid organ transplant recipients who received organs from donors with reactive syphilis tests: a retrospective cohort study","volume":"37","author":"Garc\u00eda","year":"2023","journal-title":"Clin Transplant"},{"key":"B43","year":""},{"key":"B44","doi-asserted-by":"publisher","first-page":"e13576","DOI":"10.1111\/ctr.13576","article-title":"Arenaviruses and west nile virus in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Anesi","year":"2019","journal-title":"Clin Transplant"},{"key":"B45","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/TP.0000000000000024","article-title":"Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features","volume":"97","author":"Winston","year":"2014","journal-title":"Transplantation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7326\/0003-4819-137-3-200208060-00009","article-title":"West Nile virus: a primer for the clinician","volume":"137","author":"Petersen","year":"2002","journal-title":"Ann Intern Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1399-3062.2012.00743.x","article-title":"Current practices and evaluation of screening solid organ donors for West Nile virus","volume":"14","author":"Nett","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"B48","year":""},{"key":"B49","doi-asserted-by":"publisher","first-page":"e13546","DOI":"10.1111\/ctr.13546","article-title":"Transplantation IDCoPotASo. Tissue and blood protozoa including toxoplasmosis, chagas disease, leishmaniasis, babesia, acanthamoeba, balamuthia, and naegleria in solid organ transplant recipients- guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"La Hoz","year":"2019","journal-title":"Clin Transplant"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e13154","DOI":"10.1111\/tid.13154","article-title":"Disseminated toxoplasmosis associated with hemophagocytic syndrome after kidney transplantation: a case report and review","volume":"21","author":"Gay","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e13732","DOI":"10.1111\/tid.13732","article-title":"Hemophagocytic syndrome triggered by donor-transmitted toxoplasmosis as a complication in same-donor recipients of renal transplantation: case report and review of the literature","volume":"23","author":"Vald\u00e9s Franc\u00ed","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"B52","year":""},{"key":"B53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1600-6143.2011.03444.x","article-title":"Screening and treatment of chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group","volume":"11","author":"Chin-Hong","year":"2011","journal-title":"Am J Transplant"},{"key":"B54","year":""},{"key":"B55","doi-asserted-by":"publisher","first-page":"e13618","DOI":"10.1111\/ctr.13618","article-title":"Intestinal parasites including cryptosporidium, cyclospora, giardia, and microsporidia, entamoeba histolytica, strongyloides, schistosomiasis, and echinococcus: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"La Hoz","year":"2019","journal-title":"Clin Transplant"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/j.transproceed.2015.11.045","article-title":"Donor-derived strongyloidiasis infection in solid organ transplant recipients: a review and pooled analysis","volume":"48","author":"Kim","year":"2016","journal-title":"Transplant Proc"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/ajt.13137","article-title":"Donor-derived strongyloides stercoralis infection in solid organ transplant recipients in the United States, 2009\u20132013","volume":"15","author":"Abanyie","year":"2015","journal-title":"Am J Transplant"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e13315","DOI":"10.1111\/petr.13315","article-title":"Donor-derived strongyloidiasis in a Saudi pediatric kidney transplant recipient: a case report and mini-review","volume":"23","author":"Alsager","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e13497","DOI":"10.1111\/ctr.13497","article-title":"Implementation of a strongyloides screening strategy in solid organ transplant donors and recipients","volume":"33","author":"Camargo","year":"2019","journal-title":"Clin Transplant"},{"key":"B60","year":""},{"key":"B61","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/tid.12388","article-title":"Candida arteritis in kidney transplant recipients: case report and review of the literature","volume":"17","author":"D\u0119bska-\u015alizie\u0144","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.urology.2017.04.046","article-title":"Renal arterial mycotic aneurysm after kidney transplantation","volume":"106","author":"Lazareth","year":"2017","journal-title":"Urology"},{"key":"B63","year":""},{"key":"B64","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.idc.2018.04.007","article-title":"Endemic mycoses in solid organ transplant recipients","volume":"32","author":"Nel","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13087","article-title":"Histoplasmosis in transplant recipients","volume":"31","author":"Gajurel","year":"2017","journal-title":"Clin Transplant"},{"key":"B66","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jpids\/pis086","article-title":"Allograft-transmitted histoplasma capsulatum infection in a solid organ transplant recipient","volume":"2","author":"Schwenk","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B67","year":""},{"key":"B68","doi-asserted-by":"publisher","first-page":"ofw086","DOI":"10.1093\/ofid\/ofw086","article-title":"Donor-derived coccidioides immitis endocarditis and disseminated infection in the setting of solid organ transplantation","volume":"3","author":"Nelson","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1111\/ajt.13950","article-title":"Coccidioidomycosis transmission through organ transplantation: a report of the OPTN ad hoc disease transmission advisory committee","volume":"16","author":"Kusne","year":"2016","journal-title":"Am J Transplant"},{"key":"B70","year":""},{"key":"B71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5500\/wjt.v10.i3.47","article-title":"Emerging and neglected zoonoses in transplant population","volume":"10","author":"Mrzljak","year":"2020","journal-title":"World J Transplant"},{"key":"B72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/INF.0000000000003335","article-title":"Immune reconstitution inflammatory syndrome complicating cryptococcal meningitis in a pediatric heart transplant patient","volume":"41","author":"Miller","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e13971","DOI":"10.1111\/tid.13971","article-title":"Could cell-free DNA and host biomarkers assist in antimicrobial stewardship with organ transplant recipients?","volume":"24","author":"Chang","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"B74","author":"Epperson","year":""}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1167069\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:36:51Z","timestamp":1682051811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1167069\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":74,"alternative-id":["10.3389\/fped.2023.1167069"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1167069","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"article-number":"1167069"}}